- Trevi Therapeutics to Participate in Upcoming Conferences
- Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
- Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024
- Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference
- Trevi Therapeutics to Participate in Upcoming April Events
- Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team
- Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates
- Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024
- Trevi Therapeutics to Participate in Upcoming March Events
More ▼
Key statistics
On Friday, Trevi Therapeutics Inc (TRVI:NMQ) closed at 2.84, -29.00% below its 52-week high of 4.00, set on Mar 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.85 |
---|---|
High | 2.93 |
Low | 2.75 |
Bid | 1.92 |
Offer | 2.99 |
Previous close | 2.84 |
Average volume | 119.54k |
---|---|
Shares outstanding | 70.44m |
Free float | 69.55m |
P/E (TTM) | -- |
Market cap | 200.04m USD |
EPS (TTM) | -0.338 USD |
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼